{
  "cui": "C1391732",
  "cui_name": "Cancer cachexia",
  "incidence_per_100k": 110,
  "prevalence_per_100k": null,
  "metric_type": "incidence",
  "total_cases_per_year": 8800000,
  "confidence": 0.55,
  "is_subtype": false,
  "parent_disease": "Cachexia",
  "reasoning": "Cancer-associated cachexia syndrome (weight loss, muscle wasting) develops in 50-80% of cancer patients depending on tumor type. Global cancer incidence ~200 per 100k, with approximately 50-60% developing cachexia yields ~110 per 100k. Higher rates in pancreatic, gastric, and lung cancers.",
  "data_quality": "moderate",
  "geographic_variation": "moderate",
  "year_specific": false,
  "data_year": null,
  "source": "Tisdale MJ. (2002). Cachexia in cancer patients. Nat Rev Cancer. 2(11):862-71",
  "source_url": "https://pubmed.ncbi.nlm.nih.gov/12415256/",
  "source_type": "literature"
}
